Glycemic control in diabetes mellitus: have changes in therapy made a difference?

https://doi.org/10.1016/S0002-9343(97)89453-3Get rights and content

Purpose

New methods of measuring and controlling glycemia in diabetes mellitus have been developed and implemented in the past 10 years. We examined whether glycemia, as measured by glycosylated hemoglobin, changed in outpatient insulin-dependent diabetes mellitus (IDDM) and noninsulin-dependent diabetes mellitus (NIDDM) populations between 1985 and 1993 and whether contemporaneous changes in therapy could account for observed changes in glycemia.

Patients and methods

Outpatients were selected based on having glycated hemoglobin (HbA1c) measured in the Massachusetts General Hospital laboratory during March 1985 (IDDM n = 94 and NIDDM n = 137) or during March 1993 (IDDM n = 89 and NIDDM n = 118). Chart reviews established demographic and clinical characteristics, including frequency of blood glucose self-monitoring, insulin injections, office visits, and HbA1c measurements during the year prior to the HbA1c result.

Results

Mean HbA1c level was significantly lower in the 1993 IDDM cohort compared with the 1985 cohort (8.77% ± 1.7% versus 9.47% ± 2.1%, P = 0.014). In the NIDDM cohorts, the difference in mean HbA1c did not achieve statistical significance (8.35% ± 1.6% in 1993 versus 8.75% ± 2.1% in 1985, P = 0.09); however, when adjusted for differences in NIDDM duration, HbA1c in the 1993 cohort was significantly lower than that in the 1985 cohort. The largest decrease in HbA1c in NIDDM was in patients treated with insulin (9.53% ± 2.0% versus 8.54% ± 1.5% in 1985 and 1993, respectively, P = 0.004). Multiple linear regression analyses demonstrated that increased frequency of self-monitoring and of insulin injections were associated with lower HbA1c in IDDM.

Conclusions

The level of average glycemia has decreased in IDDM patients over the past 8 years, attributable, at least in part, to an increased frequency of monitoring and of insulin injections. Glycemia decreased in NIDDM, especially in the subset of patients treated with insulin. This temporal shift in glycemic control should have a salutary effect on the development of long-term microvascular and neurologic complications.

References (21)

  • NathanDM

    Modem management of insulin-dependent diabetes mellitus

    Med Clin North Am.

    (1988)
  • KleinR et al.

    Change in glycemia in a four year interval in younger-onset insulin dependent diabetes

    Ann Epidemiol.

    (1992)
  • American Diabetes Association

    Clinical practice recommendations 1992–1993

    Diabetes Care.

    (1993)
  • Consensus Development Panel. Consensus statement on self-monitoring of blood glucose

    Diabetes Care.

    (1987)
  • NathanDM et al.

    The clinical information value of the glycosylated hemoglobin assay

    NEJM

    (1984)
  • GoldsteinDE et al.

    Clinical application of glycosylated hemoglobin measurements

    Diabetes

    (1982)
  • SingerDE et al.

    Tests of glycemia in diabetes mellitus

    Ann Intern Med.

    (1979)
  • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus

    NEJM.

    (1993)
There are more references available in the full text version of this article.

Cited by (0)

View full text